CA9 and neuroblastoma: The data here reported demonstrate the suitability of this hypothesis since ciprofloxacin and acetazolamide, inhibitors of MCM2 and CA9 activity, respectively, strongly potentiate anticancer effects of cisplatin in a heterotopic mouse model of NB.